Relevant laboratory findings in patients with sickle cell disease living at high altitude

Githens, 1977, Splenic sequestration syndrome at mountain altitudes in sickle/hemoglobin C disease, J Pediatr, 90, 203, 10.1016/S0022-3476(77)80630-6 Mahoney, 1979, Sickling crises at altitude. Occurrence in the Colorado patient population, Clin Paediatr, 18, 431, 10.1177/000992287901800711 Claster, 1981, Risk of altitude exposure in sickle cell disease, West J Med, 135, 364 Perrine, 1978, Natural history of sickle cell anemia in Saudi Arabs: a study of 270 subjects, Ann Intern Med, 88, 1, 10.7326/0003-4819-88-1-1 1982, 323 Addae, 1990, Sickle cell disease in permanent residents of mountain and low altitudes in Saudi Arabia, Trop Geo Med, 42, 342 Adzaku, 1992, Clinical features of sickle cell disease at altitude, J Wilderness Med, 3, 260, 10.1580/0953-9859-3.3.260 1989 Eaton, 1969, Role of 2,3-diphosphoglycerate in the adaptation of man to altitude, J. Lab Clin Med, 73, 603 1978 1981 Opalinski, 1971, 2,3-diphosphoglycerate and anemia, N Engl J Med, 285, 483, 10.1056/NEJM197108262850904 Torrance, 1970, Intraerythroytic adaptation to anemia, N Engl J Med, 283, 165, 10.1056/NEJM197007232830402 Samaja, 1986, The role of 2,3-DPG in the oxygen transport at altitude, Resp Physiol, 64, 191, 10.1016/0034-5687(86)90041-1 Milner, 1914, Oxygen transport in sickle cell anemia, Arch Intern Med, 133, 565, 10.1001/archinte.1974.00320160059006 Briehl, 1973, Effect of pH, 2,3-diphosphoglycerate and salts on gelation of sickle cell deoxyhemoglobin, J Mol Biol, 80, 445, 10.1016/0022-2836(73)90415-4 Jensen, 1973, Effects of cyanate and 2,3-diphosphoglycerate on sickling. Relationship to oxygenation, J. Clin Invest, 52, 2542, 10.1172/JCI107445 Poillon, 1986, The effect of 2,3-diphosphoglycerate on the solubility of deoxyhemoglobin S, Arch Biochem Biophys, 249, 301, 10.1016/0003-9861(86)90006-8